Deventer Sander Van - Net Worth and Insider Trading
Deventer Sander Van Net Worth
The estimated net worth of Deventer Sander Van is at least $725,908 dollars as of 2025-05-18. Deventer Sander Van is the EVP, Research & Product Dev. of uniQure NV and owns about 52,986 shares of uniQure NV (QURE) stock worth over $725,908. Details can be seen in Deventer Sander Van's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Deventer Sander Van has not made any transactions after 2020-01-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Deventer Sander Van
Deventer Sander Van Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deventer Sander Van owns 3 companies in total, including HOOKIPA Pharma Inc (HOOK) , uniQure NV (QURE) , and Argos Therapeutics Inc (ARGSQ) .
Click here to see the complete history of Deventer Sander Van’s form 4 insider trades.
Insider Ownership Summary of Deventer Sander Van
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| HOOK | HOOKIPA Pharma Inc | 2019-04-17 | director |
| QURE | uniQure NV | 2020-01-28 | Chief Scientific Officer |
| ARGSQ | Argos Therapeutics Inc | 2017-01-19 | director |
Deventer Sander Van Latest Holdings Summary
Deventer Sander Van currently owns a total of 1 stock. Deventer Sander Van owns 52,986 shares of uniQure NV (QURE) as of January 28, 2020, with a value of $725,908.
Latest Holdings of Deventer Sander Van
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QURE | uniQure NV | 2020-01-28 | 52,986 | 13.70 | 725,908 |
Holding Weightings of Deventer Sander Van
Deventer Sander Van Form 4 Trading Tracker
According to the SEC Form 4 filings, Deventer Sander Van has made a total of 0 transactions in uniQure NV (QURE) over the past 5 years. The most-recent trade in uniQure NV is the sale of 2,227 shares on January 28, 2020, which brought Deventer Sander Van around $137,205.
Insider Trading History of Deventer Sander Van
- 1
Deventer Sander Van Trading Performance
Deventer Sander Van Ownership Network
Ownership Network List of Deventer Sander Van
Ownership Network Relation of Deventer Sander Van
Deventer Sander Van Owned Company Details
What does HOOKIPA Pharma Inc do?
Who are the key executives at HOOKIPA Pharma Inc?
Deventer Sander Van is the director of HOOKIPA Pharma Inc. Other key executives at HOOKIPA Pharma Inc include director & Chief Financial Officer Reinhard Kandera , director & Chief Executive Officer Jorn Aldag , and Chief Medical Officer Katia Schlienger .
HOOKIPA Pharma Inc (HOOK) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of HOOKIPA Pharma Inc (HOOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HOOKIPA Pharma Inc (HOOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
HOOKIPA Pharma Inc (HOOK)'s detailed insider trading history can be found in Insider Trading Tracker table.
HOOKIPA Pharma Inc Insider Transactions
Deventer Sander Van Mailing Address
Above is the net worth, insider trading, and ownership report for Deventer Sander Van. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Deventer Sander Van's mailing address is: Naarden P7 1410 Ad.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
